Wisp, a US-based women’s telehealth company, has acquired TBD Health, a sexual health platform operating across all 50 states. The deal terms were not disclosed. This marks Wisp’s first acquisition and expands the company beyond direct-to-consumer care into enterprise and hybrid care models.
TBD Health operates a sexual health and diagnostics platform offering STI and HIV testing, TelePrEP services, and virtual clinical support. The company has partnerships with Mount Sinai Health System, San Francisco AIDS Foundation, and Planned Parenthood Direct.
“This acquisition reflects where healthcare is going and where women have been left behind,” said Monica Cepak, CEO of Wisp. “TBD Health brings the infrastructure and partnerships that allow us to move into hybrid and enterprise care quickly, while staying true to Wisp’s patient-first approach. Together, we are making preventative care more accessible especially to women and integrating them into proven care models.”
The acquisition addresses gaps in PrEP access for women. While women account for 19% of new HIV diagnoses in the United States, according to the company, most prevention models have historically been designed and marketed for men. Of the 2.4 million people eligible for PrEP treatment, only approximately 25% are currently enrolled.
“By joining forces with Wisp, we can provide partners with a turnkey solution for PrEP along with sexual health diagnostics and care that integrates seamlessly into their existing workflows, ensuring no patient falls through the cracks,” said Daphne Chen, co-founder of TBD Health.
Wisp reports serving 1.8 million patients across the United States. The company is majority-owned by WELL Health Technologies Corp. TBD Health was co-founded by Stephanie Estey, Daphne Chen, and Sherwin Lu.
